Q1 2026 · 13F-HR
Discovery Value Fundholdings as filed
Filed 2026-05-14 · accession 0001750451-26-000004
$34.7M
Reported value
1
Positions
2026-03-31
Period end
The Brief · Discovery Value Fund · Q1 2026
AI · grounded in 13F
Discovery Value Fund closed its position in Intellia Therapeutics Inc NTLA, reducing its holdings by $880,804. The fund also accumulated shares of NVIDIA Corporation NVDA, increasing its position by 1.29%. Total assets under management for the period ended March 31, 2026, stood at $34,683,626.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 67066G104 | NVDA | NVIDIA CORPORATION | $34.7M | 100.0% | 198,874 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.